Abstract
The transcription factor nuclear factor-κB (NF-κB) is comprised of a family of proteins that are implicated in a wide variety of cellular functions, including the control of cell proliferation, cell survival, and cellular differentiation. Although NF-κB is activated in response to inflammatory signals or cellular stress, in the skin NF-κB is also implicated to play a role in normal epidermal homeostasis. Often the cellular consequences of NF-κB activation are dependent on the specific triggering stimuli. Thus, we have compared the activation mechanism and the function of NF-κB following two common stimuli of normal human keratinocytes, inflammatory mediators (tumor necrosis factor alpha (TNFα)), and cellular stress (ultraviolet light B (UVB) irradiation). These experiments indicate that although both TNFα and UVB stimulate NF-κB DNA-binding activity in normal human keratinocytes, the mechanisms of NF-κB activation by each stimulus is different. In contrast to the NF-κB response following TNFα, activation of NF-κB by UVB is independent of IκBα degradation. Analyses of NF-κB-dependent gene expression following TNFα or UVB treatment demonstrate that each of these stimulatory signals results in a specific subset of genes that are activated or repressed. These studies provide further evidence of the stimuli and cell-type specific nature of NF-κB function.
Similar content being viewed by others
References
Adhami VM, Afaq F, Ahmad N (2003) Suppression of ultraviolet B exposure-mediated activation of NF-kappa-B in normal human keratinocytes by resveratrol. Neoplasia 5:74–82
Aggarwal BB (2004) Nuclear factor-κB: the enemy within. Cancer Cell 6:203–208
Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K (2002) Involvement of NF-κB signalling in skin physiology and disease. Cell Signal 15:1–7
Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, Vandenbunder B, Abbadie C (2004) Involvement of Rel/Nuclear factor-κB transcription factors in keratinocyte senescence. Cancer Res 64:472–481
Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL (1999) Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis. Oncogene 18:7423–7431
Chaturvedi V, Qin JZ, Denning MF, Choubey D, Diaz MO, Nickoloff BJ (2001) Abnormal NF-κB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. J Dermatol Sci 26:67–78
Chen LF, Greene WC (2004) Shaping the nuclear action of NF-κB. Nat Rev Mol Cell Biol 5:392–401
Chen LF, Mu Y, Greene WC (2002) Acetylation of RelA at discrete sites regulates distinct nuclear funcations. EMBO J 21:6539–6548
Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA (2003) NF-κB blockade and oncogenic ras trigger invasive human epidermal neoplasia. Nature 421:639–643
Delhalle S, Blasius R, Dicato M, Diederich M (2004) A beginner’s guide to NF-κB signaling pathways. Ann NY Acad Sci 1030:1–13
Fan C, Yang J, Engelhardt JF (2002) Temporal pattern of NFkB activation influences apoptotic cell fate in a stimuli-dependent fashion. J Cell Sci 115:4843–4853
Fujioka S, Sclabas G, Schmidt C, Niu J, Frederick W, Dong Q, Abbruzzese J, Evans D, Baker C, Chiano P (2003) Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis. Oncogene 22:1365–1370
Hinata K, Gervin AM, Zhang YJ, Khavari PA (2003) Divergent gene regulation and growth effects by NFκB in epithelial and mesenchymal cells of human skin. Oncogene 22:1955–1964
Hogerlinden MV, Rozell BL, Ahrlund-Richter L, Tofgard R (1999) Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/NF-κB signaling. Cancer Res 59:3299–3303
Jijon H, Allard B, Jobin C (2004) NF-κB inducing kinase activates NF-κB transcription activity independently of IκB kinase through a p38 MAPK-dependent RelA phosphorylation pathway. Cell Signal 16:1023–1032
Karin M (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339–27342
Kato T Jr, Delhase M, Hoffman A, Karin M (2003) CK2 is a c-terminal IκB kinase responsible for NF-κB activation during the UV response. Mol Cell 12:829–839
Kaufman C, Fuchs E (2000) It’s got you covered: NF-κB in the epidermis. J Cell Biol 149:999–1004
Kuhn C, Hurwitz SA, Kumar MG, Cotton J, Spandau DF (1999) Activation of insulin like growth factor-1 receptor promotes the survival of human keratinocytes following UVB irradiation. Int J Cancer 80:431–438
Luan B, Zhang Z, Wu Y, Kang J, Pei G (2005) β-Arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-κB activation. EMBO J 24:4237–4246
Madrid LV, Mayo MW, Reuther JY, Baldwin AS (2001) Akt stimulates the transactivation potential of RelA/p65 subunit of NFκB through utilization of the IKK and activation of the mitogen-activated protein kinase p38. J Biol Chem 276:18934–18940
Madrid LV, Wang C, Guttridge DC, Schottelius AJG, Baldwin AS, Mayo MW (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 20:1626–1638
Meng F, Liu L, Chin PC, D’Mello SR (2002) Akt is a downstream target of NF-κB. J Biol Chem 277:29674–29680
Meng F, D’Mello SR (2003) NF-κB stimulates akt phosphorylation and gene expression by distinct signaling mechanisms. Biochim Biophys Acta 1630:35–40
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37–43
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB (1999) NF-κB activation by TNFα requires the akt serine threonine kinase. Nature 401:82–85
Perkins ND (2004) Regulation of NF-kB by atypical activators and tumour suppressors. Biochem Soc Trans 32:936–939
Schmitz ML, Mattioli I, Buss H, Kracht M (2004) NF-κB: a multifaceted transcription factor regulated at several levels. Chembiochem 5:1348–1358
Seitz C, Lin Q, Deng H, Khavari PA (1998) Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc Natl Acad Sci USA 95:2307–2312
Seitz C, Freiberg RA, Hinata K, Khavari PA (2000) NF-κB determines localization and features of cell death in epidermis. J Clin Invest 105:253–260
Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G, et al (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293:1495–1499
Southall MD, Isenberg JS, Nakshatri H, Yi Q, Pei Y, Spandau DF, Travers JB (2001) The platelet-activating factor receptor protects epidermal cells from TNF and TRAIL-induced apoptosis through a NF-κB-dependent process. J Biol Chem 276:45548–45554
Takao J, Yudate T, Das A, Shikano S, Bonkobara M, Ariizumi K, Cruz PD (2003) Expression of NF-κB in epidermis and the relationship between activation and inhibition of keratinocyte growth. Br J Dermatol 148:680–688
Tergaonkar B, Bottero V, Ikawa M, Li QT, Verma IM (2003) IκB kinase-independent IκBα degradation pathway: functional NF-κB activity and implications for cancer therapy. Mol Cell Biol 23:8070–8083
Wajant H, Pfizenmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45–65
Zhang JY, Tao S, Kimmel R, Khavari PA (2005) CDK4 regulation by TNFR1 and JNK is required for NF-κB-mediated epidermal growth control. J Cell Biol 168:561–566
Acknowledgments
We are grateful to Dr. Harikrishna Nakshatri for helping us establish the EMSA protocol in our lab and we thank Dr. Jeffrey Travers for his helpful comments on the project. This work was supported by a grant from the National Institutes of Health (R01ES11155 to DFS). These studies were funded by a grant from the National Institutes of Health to DFS (R01ES11155).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lewis, D.A., Spandau, D.F. UVB activation of NF-κB in normal human keratinocytes occurs via a unique mechanism. Arch Dermatol Res 299, 93–101 (2007). https://doi.org/10.1007/s00403-006-0729-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-006-0729-2